NL
DE
18 May 2017
Approved budget: € 508,305
Project title: Comprehensive genetic monitoring of MDS and AML (sub)ciones in response to therapy
Carl Figdor, theme Cancer development and immune defense
Approved budget: € 699,474
Project title: Towards prediction of the outcome of cancer immunotherapy
Approved budget: € 517,449
Project Title: The ImmuNet: Integrating immunological parameters for personalized cancer therapy
Hans Jacobs, theme Cancer development and immune defense
Approved budget: € 510,017
Project title: Mass spectrometry as a novel ultra-sensitive platform to measure minimal residual disease in serum of patients with multiple myeloma.
Approved budget: € 1,600,246
Project title: Improving treatment decisions in colorectal cancer: the role of tumor budding
Johanna Pijnenborg, theme Women's cancers and colleagues
Approved budget: € 240,072
Project title: Towards an improved preoperative risk classification in edometrial carcinoma, a European collaborative network study
Approved budget: € 151,946
Projec title: Myeloid cell reprograming in the context of radiolodine therapy in patients with non-medullary thyroid carcinoma
This year, KWF awarded several projects from RIHS and RIMLS researchers. We congratulate our researchers with this funding and wish them a lot of success with their great work.
Research grants are for:
Leonie Kroeze, theme Cancer development and immune defenseApproved budget: € 508,305
Project title: Comprehensive genetic monitoring of MDS and AML (sub)ciones in response to therapy
Carl Figdor, theme Cancer development and immune defense
Approved budget: € 699,474
Project title: Towards prediction of the outcome of cancer immunotherapy
Young Investigator grants are for:
Johannes Textor, theme Cancer development and immune defenseApproved budget: € 517,449
Project Title: The ImmuNet: Integrating immunological parameters for personalized cancer therapy
Hans Jacobs, theme Cancer development and immune defense
Approved budget: € 510,017
Project title: Mass spectrometry as a novel ultra-sensitive platform to measure minimal residual disease in serum of patients with multiple myeloma.
Consortia grants are for:
Iris Nagtegaal, theme Tumors of the digestive tract and colleaguesApproved budget: € 1,600,246
Project title: Improving treatment decisions in colorectal cancer: the role of tumor budding
Johanna Pijnenborg, theme Women's cancers and colleagues
Approved budget: € 240,072
Project title: Towards an improved preoperative risk classification in edometrial carcinoma, a European collaborative network study
Unique high risk grant is for:
Romana Netea-Maier, theme Rare cancersApproved budget: € 151,946
Projec title: Myeloid cell reprograming in the context of radiolodine therapy in patients with non-medullary thyroid carcinoma
Related news items
Exploration meeting Academic Alliance on Oncology
2 December 2019 Within the Academic Alliance, the Maastricht UMC+ and Radboudumc are already working together in several areas. And this is happening in more and more fields. On 27 November researchers from both umc's met during the fourth Exploration meeting, this time with the theme: Oncology. read more
KWF Roadshow 11 November 2019
10 October 2019 In which way(s) can KWF provide optimal support to oncological research and care? How can we maximize impact on our investments? These questions are pivotal in Ambition 2030: the vision that KWF developed in close cooperation with stakeholders in the oncological field. read more
Internal KWF review procedure 2020
13 June 2019 In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications. read more
RIMLS awards festival Twelve winners
16 January 2019 In 5 categories RIMLS young researchers received an award and bonus during the New Year's drinks. See all photo's. read more
Report of the 12th New Frontiers symposium Better care, network care? - 2 November 2018
7 November 2018 No easy answers at this symposium last Friday, only challenges that can be overcome if we succeed in 5 things. First and most radically, put patients in the center of healthcare. Second, start with assessing what the local population needs and not what local professionals have to offer. read more
